BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22640381)

  • 1. Paediatric major depressive disorder: neurobiology and implications for early intervention.
    Cullen K; Klimes-Dougan B; Kumra S; Schulz SC
    Early Interv Psychiatry; 2009 Aug; 3(3):178-88. PubMed ID: 22640381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta-endorphin in the pathophysiology of major depression.
    Hegadoren KM; O'Donnell T; Lanius R; Coupland NJ; Lacaze-Masmonteil N
    Neuropeptides; 2009 Oct; 43(5):341-53. PubMed ID: 19647870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRH, stress, and major depression: a psychobiological interplay.
    Claes SJ
    Vitam Horm; 2004; 69():117-50. PubMed ID: 15196881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of candidate pathways underlying the association between asthma and major depressive disorder.
    Van Lieshout RJ; Bienenstock J; MacQueen GM
    Psychosom Med; 2009 Feb; 71(2):187-95. PubMed ID: 19073754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stress and depression: clinical, neurobiological and genetical perspectives].
    Claes SJ
    Tijdschr Psychiatr; 2009; 51(8):551-7. PubMed ID: 19658067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain derived neurotrophic factor and influences of stress in depression.
    Kimpton J
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S169-71. PubMed ID: 22945215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Major depressive disorder: factors of risk, vulnerability and protection].
    Olié E; Courtet P
    Encephale; 2010 Dec; 36 Suppl 5():S117-22. PubMed ID: 21211630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we use antidepressant medications for children and adolescents with depressive disorders?
    Birmaher B
    Psychopharmacol Bull; 1998; 34(1):35-9. PubMed ID: 9564196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological effects of electroconvulsive therapy and transcranial magnetic stimulation in major depression.
    Szuba MP; O'Reardon JP; Evans DL
    Depress Anxiety; 2000; 12(3):170-7. PubMed ID: 11126192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females.
    Shea A; Walsh C; Macmillan H; Steiner M
    Psychoneuroendocrinology; 2005 Feb; 30(2):162-78. PubMed ID: 15471614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depression, stress and brain function].
    Videbech P; Petersen TH
    Ugeskr Laeger; 2001 Nov; 163(47):6568-72. PubMed ID: 11760536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis.
    Klimes-Dougan B; Eberly LE; Westlund Schreiner M; Kurkiewicz P; Houri A; Schlesinger A; Thomas KM; Mueller BA; Lim KO; Cullen KR
    Dev Psychopathol; 2014 Nov; 26(4 Pt 2):1321-35. PubMed ID: 25422964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.
    Craighead WE; Dunlop BW
    Annu Rev Psychol; 2014; 65():267-300. PubMed ID: 24405361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.
    Stapelberg NJ; Neumann DL; Shum DH; McConnell H; Hamilton-Craig I
    Aust N Z J Psychiatry; 2011 May; 45(5):351-69. PubMed ID: 21500954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptor polymorphisms in major depression.
    Claes S
    Ann N Y Acad Sci; 2009 Oct; 1179():216-28. PubMed ID: 19906242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not fade away: the HPA axis and depression.
    Cowen PJ
    Psychol Med; 2010 Jan; 40(1):1-4. PubMed ID: 19335939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.